Literature DB >> 9504325

Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Mauritius NCD Study Group.

P Z Zimmet1, V R Collins, M P de Courten, A M Hodge, G R Collier, G K Dowse, K G Alberti, J Tuomilehto, F Hemraj, H Gareeboo, P Chitson, D Fareed.   

Abstract

OBJECTIVE: It has been shown previously in smaller studies that fasting serum leptin and insulin concentrations are highly correlated, and insulin sensitive men have lower leptin levels than insulin resistant men matched for fat mass. We have examined the association between insulin resistance (assessed by fasting insulin) and leptin after controlling for overall and central adiposity in a population-based cohort.
DESIGN: Leptin levels were compared across insulin resistance quartiles within three categories of obesity (tertiles of body mass index (BMI)). Partial correlation coefficents and multiple linear regression models were used to assess the relationship between leptin and fasting insulin after adjusting for BMI and waist to hip ratio (WHR) or waist circumference.
SUBJECTS: Subjects were normoglycemic participants of a 1987 non-communicable diseases survey conducted in the multiethnic population of Mauritius. 1227 men and 1310 women of Asian Indian, Creole and Chinese ethnicity had normal glucose tolerance and fasting serum leptin measurements.
RESULTS: Mean serum leptin concentration increased across quartiles of fasting insulin in each BMI group and gender, after controlling for BMI, WHR and age. Furthermore, fasting insulin was a significant determinant of serum leptin concentration, independent of BMI and WHR, in both men and women. Similar results were found if waist circumference replaced BMI and WHR in the model.
CONCLUSION: These results suggest that insulin resistance/concentration may contribute to the relatively wide variation in leptin levels seen at similar levels of body mass or alternatively, leptin may play a role in the etiology of insulin resistance. Further studies will be important to determine whether the hyperleptinemia/insulin resistance relationship has a role in the natural history of obesity, Type 2 diabetes mellitus and the other metabolic abnormalities associated with insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504325     DOI: 10.1038/sj.ijo.0800559

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  24 in total

Review 1.  Adipose tissue and vascular inflammation in coronary artery disease.

Authors:  Enrica Golia; Giuseppe Limongelli; Francesco Natale; Fabio Fimiani; Valeria Maddaloni; Pina Elvira Russo; Lucia Riegler; Renatomaria Bianchi; Mario Crisci; Gaetano Di Palma; Paolo Golino; Maria Giovanna Russo; Raffaele Calabrò; Paolo Calabrò
Journal:  World J Cardiol       Date:  2014-07-26

Review 2.  Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: A systematic review.

Authors:  Wei Bao; Aileen Baecker; Yiqing Song; Michele Kiely; Simin Liu; Cuilin Zhang
Journal:  Metabolism       Date:  2015-01-29       Impact factor: 8.694

Review 3.  Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg.

Authors:  P Zimmet; G Collier
Journal:  Drugs       Date:  1999       Impact factor: 9.546

4.  Social isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk.

Authors:  Allison Sumis; Katherine L Cook; Fabia O Andrade; Rong Hu; Emma Kidney; Xiyuan Zhang; Dominic Kim; Elissa Carney; Nguyen Nguyen; Wei Yu; Kerrie B Bouker; Idalia Cruz; Robert Clarke; Leena Hilakivi-Clarke
Journal:  Endocr Relat Cancer       Date:  2016-08-22       Impact factor: 5.678

Review 5.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

6.  Leptin cut-off values for determination of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007).

Authors:  Alireza Esteghamati; Ali Zandieh; Basira Zandieh; Omid Khalilzadeh; Alipasha Meysamie; Manouchehr Nakhjavani; Mohammad Mehdi Gouya
Journal:  Endocrine       Date:  2011-03-08       Impact factor: 3.633

7.  Loss of protein kinase Cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance.

Authors:  Wei Huang; Rishipal Bansode; Madhu Mehta; Kamal D Mehta
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

8.  Adipocytokine profile and insulin resistance in childhood obesity.

Authors:  Iuliana Gherlan; Suzana Vladoiu; Florin Alexiu; Mihaela Giurcaneanu; Sabina Oros; Andreea Brehar; Camelia Procopiuc; Constantin Dumitrache
Journal:  Maedica (Buchar)       Date:  2012-09

9.  Intermuscular adipose tissue is associated with monocyte chemoattractant protein-1, independent of visceral adipose tissue.

Authors:  Ji-Hee Haam; Young-Sang Kim; Hyung Suk Koo; Juhee Haam; Nam Kyoung Seo; Hyung Yuk Kim; Kyung-Chae Park; Kye-Seon Park; Moon Jong Kim
Journal:  Clin Biochem       Date:  2015-12-17       Impact factor: 3.281

Review 10.  Adipokines and hepatic insulin resistance.

Authors:  Yu Li; Lin Ding; Waseem Hassan; Daoud Abdelkader; Jing Shang
Journal:  J Diabetes Res       Date:  2013-05-16       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.